Magellan Health is a healthcare plans business based in the US. Magellan Health shares (MGLN) are listed on the NASDAQ and all prices are listed in US Dollars. Magellan Health employs 9,000 staff and has a trailing 12-month revenue of around $4.8 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $94.68 |
| 200-day moving average | $94.47 |
| Wall St. target price | $95.00 |
| PE ratio | 8.4858 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $11.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Magellan Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Magellan Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Magellan Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Magellan Health shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Magellan Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Magellan Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Magellan Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.8 million.
The EBITDA is a measure of a Magellan Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.8 billion |
|---|---|
| Operating margin TTM | 0.6% |
| Gross profit TTM | $120.8 million |
| Return on assets TTM | 0.54% |
| Return on equity TTM | -0.16% |
| Profit margin | 6.26% |
| Book value | $73.44 |
| Market Capitalization | $2.5 billion |
TTM: trailing 12 months
We're not expecting Magellan Health to pay a dividend over the next 12 months.
Magellan Health's shares were split on a 1:308 basis on 5 January 2004 . So if you had owned 308 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Magellan Health shares – just the quantity. However, indirectly, the new 30700% higher share price could have impacted the market appetite for Magellan Health shares which in turn could have impacted Magellan Health's share price.
Over the last 12 months, Magellan Health's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magellan Health's is 1.0353. This would suggest that Magellan Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Magellan Health, Inc. , together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.